Page 5 - இல்லுமின இன்க் ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இல்லுமின இன்க் ஒன்றுபட்டது மாநிலங்களில். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இல்லுமின இன்க் ஒன்றுபட்டது மாநிலங்களில் Today - Breaking & Trending Today

Illumina, Inc.: Illumina Wins Patent Infringement Suit against BGI in the UK


Illumina, Inc.: Illumina Wins Patent Infringement Suit against BGI in the UK
Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Ltd.
The Court found that four of the five asserted patents were valid and infringed by BGI. The Court ruled that BGI s StandardMPS and CoolMPS systems infringe EP 1 530 537 B1, EP 3 002 289 B1, and EP 3 587 433 B1, and that StandardMPS also infringes EP 2 021 415 B1. These patents cover different aspects of Illumina s proprietary sequencing-by-synthesis chemistry, including its azidomethyl reversible terminator and labelled nucleotides. ....

Hong Kong , United Kingdom , Karen Birmingham , Juliet Cunningham , Charles Dadswell , Tech Co , Chancery Division , Genomics Hong Kong Co Ltd , Patents Court , Illumina Inc , International Sales Co Ltd , High Court , General Counsel , ஹாங் காங் , ஒன்றுபட்டது கிஂக்டம் , கரேன் பர்மிங்காம் , ஜூலியட் கன்னிங்ஹாம் , தொழில்நுட்பம் இணை , சான்சரி பிரிவு , மரபியல் ஹாங் காங் இணை லிமிடெட் , காப்புரிமைகள் நீதிமன்றம் , இல்லுமின இன்க் , சர்வதேச விற்பனை இணை லிமிடெட் , உயர் நீதிமன்றம் , ஜநரல் ஆலோசனை ,

Illumina CEO Says Business Is Bouncing Back


Dreamstime
Covid-19 lockdowns kept many scientists from their labs, and the interruption showed in the mid-2020 results of
Illumina,
the supplier of technology for reading the genetic code.
Illumina’s business has now bounced back, its chief executive, Francis deSouza, told an online audience at J.P. Morgan’s annual health-care conference on Monday. He said that December 2020 quarter revenue was $950 million, or roughly flat with the quarter a year ago. Analysts had expected less than $880 million. Earnings for the December quarter were $1.20 a share, adjusted for certain one-time charges, compared with expectations for $1.05 a share.
Revenue should grow by 17% to 20% in 2021, deSouza said, and produce 2021 year earnings between $5.10 and $5.35 a share (also adjusting away expected noncash charges). ....

Bristol Myers Squibb , Bristol Myers , National Health Service , Kura Oncology , Bill Alpert , Medical Equipment Supplies , Healthcare Life Sciences , Medical Laboratory Services , Clothing Textiles , Consumer Goods , Medical Diagnostic Equipment Supplies , Healthcare Support Services , Medical Clinical Diagnostic Services , Medical Devices Apparatus , Diagnostic Therapeutic Devices , Corporate Changes , Stock Listings , Financial Performance , Earnings Projections , Corporate Funding , Share Capital , Initial Public Offerings , Corporate Actions , Corporate Industrial News , Senior Level Management , Political General News ,